On this episode of This Week in Pharmacy, we spotlight two major conversations shaping the future of pharmacy practice in 2026.
First, we welcome Dr. Lisa Faast, PharmD, founder of DiversifyRx, to discuss the Pharmacy Profit Summit 2026 and how independent pharmacies can strengthen margins, diversify revenue streams, and build sustainable growth models in today’s reimbursement environment.
Then, we turn to Rare Disease Day 2026 with Richard Faris, PharmD, Chief Commercial & Clinical Officer at PANTHERx Rare, to discuss specialty pharmacy leadership, pharmacist impact, and new patient feedback data revealing communication gaps in rare disease care.
Segment 1: Pharmacy Profit Summit 2026
Guest: Dr. Lisa Faast, PharmD | Founder, DiversifyRx
Dr. Faast joins us to break down the vision behind Pharmacy Profit Summit 2026 — an event designed to equip pharmacy owners with practical strategies to increase profitability while maintaining clinical excellence.
Key Topics Covered:
• Why independent pharmacies must move beyond traditional dispensing revenue
• Diversification strategies including niche services and high-value offerings
• Real-world financial benchmarks pharmacy owners should track
• How mindset, leadership, and data discipline drive sustainable profitability
• The importance of collaboration and shared intelligence among pharmacy entrepreneurs
The Pharmacy Profit Summit is not just about revenue — it’s about equipping pharmacy owners to compete intelligently in a rapidly consolidating healthcare market.
Segment 2: Rare Disease Day 2026
 | Guest: Richard Faris, PharmD PANTHERx Rare Pharmacy |
In recognition of Rare Disease Day 2026, we are honored to welcome Richard Ferris, PharmD, to discuss the critical role pharmacists play in specialty pharmacy and rare disease care.
PANTHERx Rare recently released survey findings examining patient and caregiver experiences within rare disease treatment journeys.